Day 5- Hematologic Emergencies

Other Hematologic Emergencies (not discussed elsewhere) include…

BLASTS+IN+THE+BLOOD+updated+2.png
  • APML

  • Febrile Neutropenia

  • Tumour Lysis Syndrome

APML

  • If you see “blasts” on the peripheral smear- consider APML ! This is a hematologic emergency, and immediate treatment with All-trans retinoid acid should be arranged.

  • Classically >10% blasts on smear (but realistically if your blood smear reports any blasts this is cause for alarm and requires hematology review)


Tumor Lysis Syndrome

  • podcast and infographic pending!

  • massive and abrupt release of cellular contents (nucleic acids, proteins, phosphorus, potassium) into bloodstream after rapid lysis of malignant cells

  • treatment induced: classically 12-72 hours post initiation of cytotoxic treatment for hematologic malignancy (can occur rarely with solid tumours)

  • High: K, phosphate, uric acid

  • Low: calcium

  • AKI

    Management:

  • cardiac monitoring for arrhythmia

  • lytes/Cr/uric acid monitoring q4-6hr

  • consider early involvement of nephrology re: dialysis

  • Rrasburicase 0.2mg/kg IV daily x 5-7 days (for high uric acid)

  • Treatment of hyperkalemia, hyperphosphatemia, hypocalcemia and AKI (discussed in other blog posts)



Febrile Neutropenia

Febrile+Neutropenia.jpg
  • Temperature >38.3 or >38.0 for more than 1 hour associated with ANC <0.5 cells/mm3, or <1.0 cells/mm3 if expected to decrease to less than 0.5 cells/mm3

  • focus of infection only found in 20-30% of patients

  • Obtain blood cultures from every intravenous port and at least one peripheral, urine R+M, sputum culture, CXR, AXR

  • In the correct context consider:

    • diarrhea: stool for c.dif

    • catheter appears infected: swabs for culture and sensitivity of site

    • neurological changes: LP

    • neutropenia >7 days: consider galactomannan

Management:

  • involve hematology/oncology

  • tazocin 4.5g IV q6hr or ceftazadime 2g IV q8hr (for pseudomonas coverage) + vancomycin 1g q12hr (if suspected MRSA infection)

  • Add anti fungal coverage if neutropenia > 7 days or if hemodynamically unstable/febrile 4-7 days after initiation of broad spectrum antibiotics

The Intern at Work -